[go: up one dir, main page]

MX2019015673A - Composicion de granulos veterinarios que contiene extracto de ca?amo. - Google Patents

Composicion de granulos veterinarios que contiene extracto de ca?amo.

Info

Publication number
MX2019015673A
MX2019015673A MX2019015673A MX2019015673A MX2019015673A MX 2019015673 A MX2019015673 A MX 2019015673A MX 2019015673 A MX2019015673 A MX 2019015673A MX 2019015673 A MX2019015673 A MX 2019015673A MX 2019015673 A MX2019015673 A MX 2019015673A
Authority
MX
Mexico
Prior art keywords
extract
veterinary
amo
composition
granules containing
Prior art date
Application number
MX2019015673A
Other languages
English (en)
Spanish (es)
Inventor
Halperin Wernli Miriam
Wernli Jorge
Batista Trepp Gian
Huber Silvia
Madea Franco
Original Assignee
Creso Pharma Switzerland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Creso Pharma Switzerland Gmbh filed Critical Creso Pharma Switzerland Gmbh
Publication of MX2019015673A publication Critical patent/MX2019015673A/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/658Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05Phenols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/348Cannabaceae
    • A61K36/3482Cannabis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Otolaryngology (AREA)
  • Hospice & Palliative Care (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
MX2019015673A 2017-06-30 2018-06-25 Composicion de granulos veterinarios que contiene extracto de ca?amo. MX2019015673A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762527463P 2017-06-30 2017-06-30
PCT/IB2018/000707 WO2019002933A1 (fr) 2017-06-30 2018-06-25 Composition de granulés vétérinaires contenant un extrait de chanvre

Publications (1)

Publication Number Publication Date
MX2019015673A true MX2019015673A (es) 2020-02-26

Family

ID=63042061

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019015673A MX2019015673A (es) 2017-06-30 2018-06-25 Composicion de granulos veterinarios que contiene extracto de ca?amo.

Country Status (5)

Country Link
EP (1) EP3645119A1 (fr)
BR (1) BR112019026635A2 (fr)
CO (1) CO2020000111A2 (fr)
MX (1) MX2019015673A (fr)
WO (1) WO2019002933A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10239808B1 (en) 2016-12-07 2019-03-26 Canopy Holdings, LLC Cannabis extracts
CA3089994A1 (fr) 2018-01-31 2019-08-08 Canopy Holdings, LLC Poudre de chanvre
CA3106476A1 (fr) * 2018-07-10 2020-01-16 Cardinal Advisory Limited Formulation de composes cannabinoides
EP3864000A4 (fr) 2018-10-10 2022-08-10 Treehouse Biosciences, Inc. Synthèse du cannabigérol
CN111978417B (zh) * 2019-09-06 2021-08-06 云南汉盟制药有限公司 一种大麻多糖的提取方法及其产品和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007046086A1 (de) * 2007-09-26 2009-04-09 Heinz Prof. Dr. Letzel Pflanzenextrakt aus THC-armen Cannabis zur Behandlung von Erkrankungen
EA201791299A1 (ru) * 2014-12-12 2017-12-29 ОХАЙ ЭНЕРДЖЕТИКС ПиБиСи Микроинкапсулированные композиции каннабиноидов

Also Published As

Publication number Publication date
WO2019002933A1 (fr) 2019-01-03
BR112019026635A2 (pt) 2020-06-30
EP3645119A1 (fr) 2020-05-06
CO2020000111A2 (es) 2020-01-17

Similar Documents

Publication Publication Date Title
CO2020000111A2 (es) Composición de gránulos veterinarios que contiene extracto de cáñamo
CL2020000632A1 (es) Composición y método para el tratamiento del autismo.
CO2019001043A2 (es) Composición de cannabis
CL2020003368A1 (es) Composicion y metodo para tratar el dolor
CL2018000829A1 (es) Anticuerpos anti-cd19 humano con alta afinidad
HK1252151A1 (zh) Thca合成酶表达改变的大麻植物
MX378687B (es) Formulacion de vitamina soluble en grasa.
BR112019007798A2 (pt) veículo de liberação oral
BR112017025339A2 (pt) composições nutricionais contendo um nível elevado de inositol e usos das mesmas
CL2020003373A1 (es) Composición y método de ahorro de opiáceos
CO2019000787A2 (es) Nuevas formulaciones y composiciones de cannabis en comprimidos y métodos para su elaboración
MX2021015256A (es) Mezcla de extractos vegetales para el uso en la prevención y/o tratamiento de enfermedades intestinales inflamatorias crónicas.
CO2019007902A1 (es) Sistemas y métodos para mejorar la formación y densidad de tricomas en cannabis
MX2015011255A (es) Composicion a base de flavonoides para uso farmaceutico, nutricional o cosmetico que tiene accion antioxidante potenciada.
CO2021002085A2 (es) Composiciones de curcuminoides
BR112015020365A2 (pt) fração bioativa derivada de fruta, composição, e método para isolar uma fração bioativa
CL2020003374A1 (es) Composicion y metodo de cannabinoides para tratar el tept y/o la ansiedad
KR102403795B9 (ko) 헴프씨드 추출물을 포함하는 항알레르기성 또는 항산화용 조성물
CL2017002967A1 (es) Beta-caseinas a2 y capacidad antioxidante.
EA201991659A1 (ru) Композиция от кашля
MA40645A (fr) Préparation prébiotique à base d'inuline
MX2017005700A (es) Composiciones de microesferas de gas encapsuladas en lipidos y metodos relacionados.
MY162437A (en) Solid composition
MX2019006547A (es) Composiciones sólidas en polvo, proceso para su preparación, formulaciones y uso de las mismas.
EA201890479A1 (ru) Гидрофобный гель на основе витамина е без продуктов силикона для местного применения